Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meda AB's Acnex Approved in Europe


Thursday, 28 Feb 2013 06:10am EST 

Meda AB announced that Acnex has received registration approval in Europe via the decentralized procedure. Acnex is a product (clindamycin/tretinoin) for the treatment of moderate to severe acne. National registration processes, including price and reimbursement, will now follow in each country. The product will be launched during 2013. 

Company Quote

101.5
2.4 +2.42%
19 Sep 2014